BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Fidson Healthcare Plc. - ECPv6.15.13//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Fidson Healthcare Plc.
X-ORIGINAL-URL:https://fidson.com
X-WR-CALDESC:Events for Fidson Healthcare Plc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260203
DTEND;VALUE=DATE:20260204
DTSTAMP:20260407T085619
CREATED:20260205T115441Z
LAST-MODIFIED:20260206T071103Z
UID:231950-1770076800-1770163199@fidson.com
SUMMARY:Fidson Hosts UNILAG VC and Global Health Expert in WHO Compliant Factory.
DESCRIPTION:It was such an honour to host a delegation led by the Vice-Chancellor of the University of Lagos (UNILAG)\, Professor Folasade Ogunsola\, OON\, FAS\, at our factory on Wednesday\, January 28\, 2026. \nThe strategic visit to our World Health Organization (WHO) compliant facility in Ota\, Ogun State\, was part of a broader engagement aimed at fostering robust partnerships between the academia\, industry\, and global research institutions. The discussions centered on advancing\nchild health through innovative\, accessible and locally relevant healthcare solutions as well as exploring the potential for local vaccine production. \n \nThe delegation included a renowned global health expert\, Professor Georg Holländer\, Director of the Botnar Research Centre for Child Health (BRCCH) and Medical Director of the Botnar Institute of Immune Engineering (BIIE)\, Basel\, Switzerland\, alongside Professor Matthew Ilori\, Director of the Academic Planning Unit at UNILAG. They were warmly received by our Managing Director and Chief Executive Officer\, Mr. Biola Adebayo\, a proud alumnus of UNILAG and members of the executive management team\, including Mrs. Nmaka Tijani (Associate Director\, Quality and Regulatory Affairs) and Mrs. Abibatu Ariori (Head\, Factory Operations). \n \nDuring the engagement\, Mr. Adebayo reaffirmed Fidson’s unwavering commitment to collaborative initiatives that bridge the gap between research and industrial application. Reflecting on his early years in Fidson\, he expressed gratitude for the Vice-Chancellor’s early professional support and emphasized the critical role of such partnerships in national development. \nAddressing the pivotal topic of local vaccine manufacturing\, Mr. Adebayo highlighted the immense potential within Nigeria’s pharmaceutical sector. \n“Fidson is fully equipped and ready to drive local vaccine manufacturing” Mr. Adebayo stated. “However\, sustainable success in this area requires a cohesive\necosystem involving strong government support and guaranteed offtake assurances\nfrom international bodies such as UNICEF and the World Health Organization.” \nIn her remarks\, Professor Ogunsola\, who serves on the Foundation Board of the BIIE\,\nemphasized the visit’s objectives\, which included identifying synergies for local vaccine\nproduction\, creating internship and sabbatical opportunities for students and faculty\, and\nstrengthening the academia-industry pipeline. \n \nSimilarly\, Professor Holländer provided a compelling scientific context for the potential\ncollaboration\, noting that current global immunology research often relies on narrow datasets\nthat exclude the diversity of populations in the Global South. He shared insights from his\nresearch indicating significant variations in immune responses to vaccines among children in\ndifferent geographies\, such as Lagos\, London\, and Brazil. \n“Our goal at the Botnar Institute is to democratize access to life-saving treatments\,” Professor Holländer remarked. “We are working to reduce the cost of antibody therapies\, which currently exceed $1\,500 per dose\, to as low as $10. Partnering with capable local manufacturers is essential to ensuring these innovations are affordable and accessible to those who need them most.“- Professor Holländer \n\nThe visit featured a tour of Fidson’s over 43-acre facility. The delegation was introduced to our state-of-the-art manufacturing processes\, rigorous quality assurance processes\, human capital development and safety culture. \nThe visiting team commended Fidson for its scale of operations and adherence to global best practices\, validating the company’s position as the leader in the pharmaceutical landscape.
URL:https://fidson.com/event/fidson-hosts-unilag-vc-and-global-health-expert-in-who-compliant-factory/
ATTACH;FMTTYPE=image/jpeg:https://fidson.com/wp-content/uploads/2026/02/1004019155-scaled.jpg
END:VEVENT
END:VCALENDAR